Gerresheimer (ETR:GXI) has been assigned a €83.00 ($96.51) price target by equities researchers at Deutsche Bank in a report released on Friday, Borsen Zeitung reports. The firm currently has a “buy” rating on the stock. Deutsche Bank’s target price indicates a potential upside of 12.70% from the stock’s previous close.
Several other research firms also recently weighed in on GXI. JPMorgan Chase & Co. set a GBX 3,200 ($41.81) target price on Diageo and gave the stock a “neutral” rating in a research report on Wednesday. Kepler Capital Markets set a €19.00 ($22.09) target price on Rhoen Klinikum and gave the stock a “sell” rating in a research report on Thursday, April 11th. DZ Bank restated a “neutral” rating on shares of Gerresheimer in a report on Thursday. Berenberg Bank restated a “buy” rating and issued a GBX 100 ($1.31) price objective on shares of in a report on Thursday. Finally, Hauck & Aufhaeuser set a €50.00 ($58.14) price objective on Gerresheimer and gave the stock a “sell” rating in a report on Friday. Three analysts have rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the stock. Gerresheimer presently has an average rating of “Hold” and a consensus price target of €69.17 ($80.43).
ETR GXI opened at €73.65 ($85.64) on Friday. The stock’s 50-day simple moving average is €65.08. Gerresheimer has a twelve month low of €51.10 ($59.42) and a twelve month high of €80.25 ($93.31). The stock has a market capitalization of $2.31 billion and a P/E ratio of 12.90. The company has a debt-to-equity ratio of 68.19, a current ratio of 0.78 and a quick ratio of 0.51.
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Featured Article: How to calculate compound interest
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.